4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
KALA BIO, Inc. (KALA) operates in the Biotechnology industry and is headquartered in Arlington, United States with about 6 employees. Its market capitalization is roughly $14 million. In the fiscal year ended 2025-12-31, KALA reported $0M in revenue and ($27M) in net income.
KALA BIO, Inc., a biopharmaceutical company, engages in the development of an on-premises artificial intelligence (AI) infrastructure platform for biotechnology research applications in the United States. The company develops Researgency, an agentic AI research platform for private enterprise AI deployment.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $4M | — |
| Gross Profit | — | — | $0M | $1M | $7M |
| Operating Income (EBIT) | ($39M) | ($34M) | ($34M) | ($81M) | — |
| Net Income | ($27M) | ($38M) | ($42M) | ($45M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($2M) | ($10M) | ($10M) | ($10M) | ($8M) | — |
| Net Income | ($2M) | $1M | ($8M) | ($11M) | ($9M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $10M | $56M | $56M | $87M | — |
| Total Liabilities | $2M | $43M | $48M | $68M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive KALA viewer.
About TickerBase · Data methodology & sources